InvestorsHub Logo
Post# of 251581
Next 10
Followers 826
Posts 119467
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 197737

Monday, 07/24/2017 11:59:18 AM

Monday, July 24, 2017 11:59:18 AM

Post# of 251581
NVS submits IPRs against Humira formulation* and psoriasis-dosing† patents:

http://www.jdsupra.com/legalnews/sandoz-files-two-petitions-for-ipr-of-17917/

*8,802,100
†9,512,216

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.